Joy L Maxwell, RN | |
621 W Madrone St, Roseburg, OR 97470-3090 | |
(541) 440-3532 | |
(541) 440-3554 |
Full Name | Joy L Maxwell |
---|---|
Gender | Female |
Speciality | Counselor |
Location | 621 W Madrone St, Roseburg, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134483316 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 093003101RN (Oregon) | Secondary |
101Y00000X | Counselor | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joy L Maxwell, RN 621 W Madrone St, Roseburg, OR 97470-3090 Ph: (541) 440-3532 | Joy L Maxwell, RN 621 W Madrone St, Roseburg, OR 97470-3090 Ph: (541) 440-3532 |
News Archive
Persistent anxiety is one of the most common and distressing symptoms compromising mental health. Most of the research on the neurobiology of anxiety has focused on the generation of increased anxiety, i.e., the processes that "turn on" anxiety.
Merz Pharmaceuticals today announced that the United States Food and Drug Administration has approved Xeomin (incobotulinumtoxinA), a botulinum toxin type A for the treatment of adults with cervical dystonia or blepharospasm. According to an epidemiology study conducted in Rochester, Minnesota, the prevalence of focal dystonia, which includes cervical dystonia and blepharospasm, is estimated at 295 per million people in the U.S.
Cancer is caused by the growth of an abnormal cell which harbours DNA mutations, "copy errors" occurring during the DNA replication process. If these errors do take place quite regularly without having any damaging effect on the organism, some of them affect a specific part of the genome and cause the proliferation of the mutant cell, which then invades the organism.
Amyloid beta pathology - protein deposits in the brain - might have been transmitted by contaminated neurosurgical instruments, suggests a new UCL-led study.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
› Verified 6 days ago